Drugs, vaccines manufacturing facility in Matugga

Dei BioPharma Ltd is a biotech and pharmaceutical research firm duly incorporated in Uganda, specializing in the development and manufacture of innovative medicines and vaccines.

The development of our iconic drugs and vaccines manufacturing facility situated at Mattuga, Wakiso District, near Kampala in Uganda, was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President).

The state-of-the-art facility, valued at USD 1.1 billion shall produce high-quality medicines across a wide range of therapeutic areas. These include malaria, cancer, generics, beta-lactums, non betalactums, nutraceuticals, parentals, Heparin, APIs, Insulin, Glagine, vaccines and monocolonal antibodies.

The manufacturing facility is gearing to produce one billion doses of mRNA vaccines guided by the most stringent global GMP including the US FDA, EU (EMA) and the World Health Organization (WHO) standards.

Dei Biopharma Ltd is currently valued at USD 2.5 billion.

President Yoweri Museveni and his Kenyan counterpart William Ruto commissioned the project in 2021, and were optimistic this would propel Africa’s capacity.

What we believe in

Our Vision

To create business opportunities and solutions for Africa through production of quality medicines using the latest innovative processes. To be the most preferred partner of choice of contract manufacturing and pharmaceutical branding

Our Mission

We aspire to become a globally acclaimed pharmaceutical company that produces a diverse portfolio of vaccines and low cost drugs, which treat diseases that afflict most people. We also seek to empower Africa through innovation, research, manufacturing and technology.

  • Innovation
  • Quality
  • Reliability 
  • Integrity 
  • Research and Development
  • Customer Focus
  • Collaboration
  • Teamwork

What the numbers say

0b
Investment.
The company now needs USD 600 million to finish the construction of the facility, offset some obligations
0k
Jobs on the market
expected to employ 40,000 people directly and tens of thousands of others in the value chain
0m
Vaccines doses.
The Only African pharmaceutical company now manufacturing the Covid-19 therapeutic medications
0
Formulations
capable of producing a wide range of potential drugs, vaccines, anti-cancer drugs, therapeutic proteins, etc

Project Financing

The development of the facility has been financed through partner funding from the Equity Group and several other funders including the Uganda Development Bank (UDB), with funds being used for construction works, importation of Hi-Tech Medical Equipment and machines as well as working capital support.
Dei BioPharma Ltd.